Medical Market Report

Global Point-of-Care Diagnostics Market By Type (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, Other), By Application (Home, Hospitals, Ambulatory Care), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135523
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global Point-of-Care Diagnostics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The Global point-of-care diagnostics Market is segmented on the basis of Type, Application, and geography.
    The Global Point-of-Care Diagnostics Market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Point-of-Care Diagnostics Market Scope:

    By type, the market is segmented into Glucose Monitoring Kits, Infectious Diseases Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Monitoring Kits, Hematology Testing Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs-Of-Abuse Testing Kits, Tumor/Cancer Markers, and Other. By Application, the market is divided into Home, Hospitals, and Ambulatory Care.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abbott Laboratories, Abaxis, Alere, Bayer, Danaher Corporation, Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens Healthcare, and Samsung Medison.

    Key Market Segments

    Type

    Glucose Monitoring Kits
    Infectious Diseases Testing Kits
    Cardiometabolic Monitoring Kits
    Coagulation Monitoring Kits
    Hematology Testing Kits
    Urinalysis Testing Kits
    Cholesterol Test Strips
    Drugs-Of-Abuse Testing Kits
    Tumor/Cancer Markers
    Other

    Application

    Home
    Hospitals
    Ambulatory Care

    Key Market Players included in the report:

    Abbott Laboratories
    Abaxis
    Alere
    Bayer
    Danaher Corporation
    Becton Dickinson
    Johnson & Johnson
    Nipro
    Roche Diagnostics
    Siemens Healthcare
    Samsung Medison

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Point-of-Care Diagnostics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Point-of-Care Diagnostics Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global Point-of-Care Diagnostics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the Global Point-of-Care Diagnostics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global Point-of-Care Diagnostics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global Point-of-Care Diagnostics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global Point-of-Care Diagnostics Market sub-markets, depending on key regions (various vital states).
    To analyze Global Point-of-Care Diagnostics Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global Point-of-Care Diagnostics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global Point-of-Care Diagnostics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global Point-of-Care Diagnostics Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Point-of-Care Diagnostics Market Overview
    

    3.1. Global Point-of-Care Diagnostics Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Point-of-Care Diagnostics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Point-of-Care Diagnostics Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Glucose Monitoring Kits
    
4.4. Infectious Diseases Testing Kits
    
4.5. Cardiometabolic Monitoring Kits
    
4.6. Coagulation Monitoring Kits
    
4.7. Hematology Testing Kits
    
4.8. Urinalysis Testing Kits
    
4.9. Cholesterol Test Strips
    
4.10. Drugs-Of-Abuse Testing Kits
    
4.11. Tumor/Cancer Markers
    
4.12. Other5. Global Point-of-Care Diagnostics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Point-of-Care Diagnostics Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Home
    
5.4. Hospitals
    
5.5. Ambulatory Care6. Global Point-of-Care Diagnostics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Global Point-of-Care Diagnostics Market: Regional Trend Analysis
    

    6.1.1. 1.US
    
6.1.1. 2.Canada
    
6.1.1. 3.Mexico
    

    6.2. Europe
    

    6.2.1. Europe Global Point-of-Care Diagnostics Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Global Point-of-Care Diagnostics Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4.India
    
6.3.1.5.Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Global Point-of-Care Diagnostics Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Global Point-of-Care Diagnostics Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Point-of-Care Diagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Abbott Laboratories
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Abaxis
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Alere
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. Bayer
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Danaher Corporation
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Becton Dickinson
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Johnson & Johnson
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. Nipro
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Roche Diagnostics
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Siemens Healthcare
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Samsung Medison
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.